Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
“Global Embolization Particle Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global embolization particle market report has been segmented on the basis of static equipment, rotating equipment, and region.
Global Embolization Particle Market: Introduction
Embolization procedures may reduce or cut off the supply of blood to a tumor. Radiologist uses imaging guidance to insert a catheter into a primary artery and advance it to blood vessel leading to a tumor or other area where the bloody supply needs to be blocked. Special substances which clot and form a blockage are then injected. Embolization may often be used to treat internal bleeding and help to prevent heavy bleeding during surgery. In some cases, embolization may be a treatment option for difficult-to-reach and inoperable tumors. It may also be used to treat tumors that are too large to be ablated.
Global Embolization Particle Market: Dynamics
Rising demand for diagnostics and treatment options for cancer is a major factor expected to drive growth of the global embolization particle market. In addition, increasing prevalence of chronic diseases across the globe and rising number of patient pool with various oncological conditions is resulting in increasing demand for different embolization particles are some other factors expected to support growth of the global market over the forecast period.
Moreover, increasing adoption of embolization particle for treatment of various types of cancer such as liver cancer, brain cancer, and lung cancer is another factor expected to support growth of the global market to certain extent.
However, lack of skilled professionals is a major factor expected to hamper growth of the global embolization particle market to certain extent.
Increasing investment by major players for R&D activities and advancements are expected to create new opportunities in terms of revenue for players operating in the target market over the forecast period. In addition, strategic approach by major players for business expansion is expected to create lucrative opportunities in terms of revenue which is further expected to support growth of the global market to certain extent.
Global Embolization Particle Market: Region Analysis
The market in North America is expected to dominate the global embolization particle market in terms of revenue and is expected to continue its dominance over the forecast period. The dominance can be attributed to well-developed healthcare infrastructure, favorable reimbursement policies, and presence of major players operating in the countries in this region. In addition, increasing merger and acquisition activities among regional and international players is expected to further support growth of the market over the forecast period. The market in Asia Pacific is expected to witness faster growth, owing to increasing number of patients suffering from chronic diseases, increasing government expenditure on healthcare sector, and presence of prominent players operating in emerging economies such as India and China in the region. The market in Latin America is expected to witness moderate growth, owing to increasing presence of prominent manufacturers in developing countries such as Brazil and Argentina in this region.
Global Embolization Particle Market Segmentation:
By Particle Type:
- Drug-Eluting Beads (DEBs)
- Radio-Embolic Microspheres
- Trauma Embolization
- Liver Tumor Embolization
- Prostatic Artery Embolization
- Uterine Fibroid Embolization
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Sirtex Medical Limited
- Boston Scientific Corporation
- Merit Medical Systems, Inc.
- BTG International Ltd.
- Cook Medical Incorporated
- Interface BIOmaterials
Request for TOC
Don't just take our word. We are trusted by these great companies!